Gene–environment interactions are key contributors to complex disease, but are hard to dissect in commonly used case–control designs. This article argues that large-scale prospective cohort studies, several of which are planned or under way, provide an essential alternative strategy.
- Teri A. Manolio
- Joan E. Bailey-Wilson
- Francis S. Collins
